Key Moments
229 ‒ Understanding cardiovascular disease risk, cholesterol, and apoB
Peter Attia MDKey Moments
Understanding cardiovascular disease risk, focusing on ApoB as a key metric over LDL.
Key Insights
Atherosclerotic cardiovascular disease (ASCVD) is an inevitable disease of aging, affecting a significant portion of the population before age 65.
Cholesterol is essential for life, playing a crucial role in cell membranes and hormone production, and is not inherently 'good' or 'bad'.
Apolipoprotein B (ApoB) is a superior metric for predicting cardiovascular risk as it counts all atherogenic particles, unlike LDL cholesterol.
Current 10-year risk assessment models for ASCVD are flawed because they underestimate risk in younger individuals and focus on probability rather than singular event prediction.
The concept of 'good' and 'bad' cholesterol is an oversimplification; the issue lies with the lipoproteins (like LDL and HDL) and their roles, not the cholesterol itself.
Mendelian randomization studies strongly support the causal link between ApoB levels and cardiovascular disease, suggesting lower is better.
While smoking and hypertension are significant risk factors, understanding and lowering ApoB levels provides a more direct and measurable approach to ASCVD prevention.
THE UBIQUITY AND IMPORTANCE OF ASCVD
Atherosclerotic cardiovascular disease (ASCVD) is presented as an inevitable disease of aging, unlike cancer or dementia. Understanding ASCVD is crucial because its impact is immense, and effective tools exist to mitigate its risks. Delaying the onset of chronic diseases like ASCVD is a core component of extending healthspan in longevity science. Key behavioral risk factors apart from smoking include hypertension and lipid abnormalities, which are central to this discussion.
ASCVD IS NOT JUST A DISEASE OF OLD AGE
Contrary to popular belief, ASCVD is not solely a disease of the elderly. Statistics reveal that over 50% of men and one-third of women experience their first major cardiac event before the age of 65. This highlights the critical need for younger individuals to understand and address their cardiovascular risk factors early, as the disease begins its development decades before clinical symptoms manifest, making early prevention strategies vital.
UNDERSTANDING CHOLESTEROL AND ITS ROLE
Cholesterol is a vital lipid molecule essential for life, integral to cell membranes and the production of hormones like cortisol, estrogen, and testosterone. It is also necessary for bile acid synthesis, aiding in food digestion. The body synthesizes most of its cholesterol, with dietary cholesterol having a minimal impact due to poor absorption. Therefore, cholesterol itself is not inherently 'good' or 'bad,' but rather a fundamental component essential for cellular function and survival.
LIPOPROTEINS: THE VEHICLES FOR CHOLESTEROL TRANSPORT
Since cholesterol is hydrophobic, it requires transport vehicles called lipoproteins to circulate in the bloodstream. These particles consist of both lipid and protein components. Major lipoprotein families are defined by apolipoproteins like ApoB and ApoA. ApoB-containing lipoproteins, including VLDL, IDL, and LDL, carry cholesterol to tissues, while ApoA-containing lipoproteins, like HDL, are involved in cholesterol transport back to the liver. The density of these lipoproteins leads to classifications like LDL (lower density) and HDL (higher density).
THE LIMITATIONS OF STANDARD CHOLESTEROL TESTING AND THE RISE OF APOB
Standard lipid panels often provide calculated LDL cholesterol, which can be inaccurate. ApoB, counting all atherogenic particles, is proposed as a superior biomarker for cardiovascular risk assessment. Unlike LDL cholesterol, ApoB provides a comprehensive measure of all particles that can contribute to plaque buildup. Mendelian randomization studies strongly support ApoB's causal role in ASCVD, indicating that lower ApoB levels are associated with reduced risk.
APPLICATIONS OF APOB IN CLINICAL PRACTICE AND PREVENTION STRATEGIES
The understanding of ASCVD natural history suggests that prevention strategies based solely on 10-year risk may be insufficient, particularly for younger individuals. Evidence supports an aggressive approach to lowering ApoB levels, ideally to infantile levels (30-40 mg/dL), starting in younger adulthood. This proactive strategy aims to prevent the disease process before significant arterial damage occurs. While smoking and hypertension remain critical risk factors, focusing on ApoB reduction offers a measurable and actionable path toward mitigating cardiovascular risk effectively.
DEBUNKING THE 'GOOD' AND 'BAD' CHOLESTEROL MYTH
The common designation of HDL as 'good' cholesterol and LDL as 'bad' cholesterol is an oversimplification and scientifically inaccurate. Both HDL and LDL are lipoproteins that transport the same type of cholesterol. The issue lies in the function and number of these particles. LDL particles, when numerous, can infiltrate artery walls, leading to oxidation and inflammation, thus contributing to atherosclerosis. HDL's role is more complex, and simply having high HDL cholesterol doesn't guarantee good health, as its functionality is key.
ADDRESSING HYPERTENSION AND ITS INTERPLAY WITH LIPIDS
Hypertension is a significant ASCVD risk factor that appears to weaken the endothelium, creating pathways for atherogenic particles. While an increase in blood pressure is common with aging, its precise pathophysiology remains debated. The relationship between hypertension and lipid levels is complex; elevated blood pressure can act as a driving force, pushing particles into the arterial wall. However, the exact mechanisms by which hypertension exerts its influence are still areas of active research, underscoring the multifactorial nature of ASCVD.
THE ROLE OF PARTICLE NUMBER AND QUALITY IN ASCVD
Beyond just the number of atherogenic particles (measured by ApoB), their 'quality' or specific attributes may also influence atherogenicity. Factors like oxidation and other proteins within the lipoprotein structure could play a role. While reducing ApoB levels is paramount, acknowledging the complexity of the arterial wall's response and potential endothelial dysfunction is also important. Individualized risk assessment considers these nuances to create tailored prevention strategies.
REDUCING APOB AND THE CONCEPT OF 'LOWER IS BETTER'
The principle of 'lower is better' is generally applied to ApoB reduction. While significant risk reduction is seen when lowering ApoB substantially, the exact dose-response curve at very low levels is still being elucidated. Pharmacological interventions, particularly PCSK9 inhibitors, allow for significant reduction of ApoB, even to levels seen in newborns, without apparent harm. This supports the idea that aggressively lowering ApoB is a safe and effective strategy for cardiovascular risk mitigation.
UNDERSTANDING CHOLESTEROL POOLS AND THERAPEUTIC TARGETS
It's crucial to understand that plasma cholesterol levels measured in blood tests represent only a small fraction of the body's total cholesterol. The vast majority is contained within cell membranes, including red blood cells. Modulating plasma lipid levels through lifestyle or medication does not significantly impact the cholesterol content within cellular membranes. Therefore, concerns about excessively low plasma cholesterol levels negatively affecting cellular function are generally unfounded, as cells can synthesize their own cholesterol.
THE FUTURE OF ASCVD PREVENTION AND THE ADVOCACY FOR APOB
The podcast advocates for a shift towards earlier and more aggressive intervention in ASCVD prevention, largely driven by the measurement and management of ApoB. The growing incidence of ASCVD despite statin therapy suggests limitations in current approaches, particularly with increasing rates of obesity and diabetes. By focusing on a simpler, more accurate metric like ApoB, clinicians can better identify and treat individuals at high risk, potentially eliminating deaths from atherosclerotic causes with timely and targeted interventions.
Mentioned in This Episode
●Organizations
●Books
●Concepts
●People Referenced
Common Questions
ASCVD is considered inevitable because it affects nearly everyone who lives long enough, unlike other prevalent diseases like cancer or dementia. While not everyone dies from it, the underlying process is highly ubiquitous with aging.
Topics
Mentioned in this video
High blood pressure, identified as one of the two biggest non-smoking risk factors for cardiovascular disease.
A disease characterized by the buildup of cholesterol sterols in artery walls, leading to plaques that can reduce blood flow and cause heart attacks or strokes. Considered an inevitable disease with aging.
The primary focus of the episode, described as a disease state characterized by cholesterol deposition in artery walls, leading to potential blockages and heart attacks or strokes.
A type of fat found in the blood. High triglyceride levels are associated with increased risk of heart disease, often due to increased VLDL particles, and can increase the risk of pancreatitis.
A protein that coats atherogenic lipoproteins (like LDL, IDL, VLDL) and is a key metric for assessing cardiovascular risk.
A measurement of the quantity of LDL particles circulating in the blood, considered a more accurate index of risk than LDL cholesterol.
Refers to abnormal levels of lipids in the blood, a major risk factor for atherosclerotic cardiovascular disease.
Abnormal functioning of the endothelium (the inner lining of blood vessels), thought to play a role in atherosclerosis and hypertension. Its exact role and mechanisms are still being investigated.
A genetic disorder characterized by extremely high LDL cholesterol levels from birth, often requiring early and aggressive treatment.
A component of blood that carries cholesterol and carries more cholesterol than all circulating lipoproteins combined, highlighting that plasma lipid levels don't reflect total body cholesterol.
A laboratory metric measuring the amount of cholesterol within LDL particles. It is often inaccurately conflated with LDL particles themselves.
A protein family associated with High-Density Lipoproteins (HDL).
A laboratory metric measuring the amount of cholesterol within HDL particles. It is often inaccurately conflated with HDL particles themselves.
A cluster of conditions including high blood pressure, high blood sugar, unhealthy cholesterol levels, and abdominal obesity, which increase the risk of heart disease, stroke, and diabetes.
An organic molecule in the lipid family, essential for cell membranes, hormone production, and bile acid synthesis. It is hydrophobic and requires lipoproteins for transport in the bloodstream.
Calculated by subtracting HDL cholesterol from total cholesterol, this metric is considered a better indicator of ASCVD risk than LDL cholesterol alone.
The amount of blood the heart pumps per minute, a factor that may influence blood pressure regulation.
A key figure and author in the field of mendelian randomization studies, particularly concerning lipid metabolism and cardiovascular risk.
Peter Attia's professional website and brand, offering content and a subscription service.
Host of The Drive podcast, focusing on translating longevity science.
Spherical molecules made of lipids and proteins that transport cholesterol and other fats through the bloodstream. They are categorized by their density and apolipoprotein content (e.g., ApoB and ApoA).
A class of injectable medications that significantly lower LDL cholesterol and ApoB levels, often used for patients with high cardiovascular risk or genetic lipid disorders.
More from Peter Attia MD
View all 168 summaries
135 min381‒Alzheimer’s disease in women: how hormonal transitions impact the brain, new therapies, & more
9 minIs Industrial Processing the Real Problem With Seed Oils? | Layne Norton, Ph.D.
13 minCooking with Lard vs Seed Oils | Layne Norton, Ph.D.
146 min380 ‒ The seed oil debate: are they uniquely harmful relative to other dietary fats?
Found this useful? Build your knowledge library
Get AI-powered summaries of any YouTube video, podcast, or article in seconds. Save them to your personal pods and access them anytime.
Try Summify free